A phase II trial of brivanib in recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group Study

Title
A phase II trial of brivanib in recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group Study
Authors
Keywords
-
Journal
GYNECOLOGIC ONCOLOGY
Volume 135, Issue 1, Pages 38-43
Publisher
Elsevier BV
Online
2014-07-12
DOI
10.1016/j.ygyno.2014.07.083

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started